{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:21:26Z","timestamp":1783052486173,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070192"],"award-info":[{"award-number":["82070192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170217"],"award-info":[{"award-number":["82170217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-073"],"award-info":[{"award-number":["2021-I2M-1-073"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022 TSHRM08003"],"award-info":[{"award-number":["2022 TSHRM08003"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-12M-C\uff06T-B-092"],"award-info":[{"award-number":["2022-12M-C\uff06T-B-092"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["T-B-091"],"award-info":[{"award-number":["T-B-091"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.intimp.2023.111165","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:22:32Z","timestamp":1699143752000},"page":"111165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PA","title":["Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD"],"prefix":"10.1016","volume":"125","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-5374","authenticated-orcid":false,"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.111165_b0005","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2014.11.007","article-title":"Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.intimp.2023.111165_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clml.2019.11.019","article-title":"Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single-Center Experience","volume":"20","author":"Kerbage","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.intimp.2023.111165_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2015.288","article-title":"New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT","author":"Chang","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.111165_b0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00277-023-05093-w","article-title":"Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation","volume":"102","author":"Park","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.intimp.2023.111165_b0025","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3390\/jcm9072204","article-title":"A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment","volume":"9","author":"Lamure","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.111165_b0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/bmt.2009.26","article-title":"Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect","volume":"44","author":"Huang","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.111165_b0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol. Blood Marrow Transplant J. Am. Soc. Blood Marrow Transplant"},{"key":"10.1016\/j.intimp.2023.111165_b0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ejh.13925","article-title":"Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Zheng","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.intimp.2023.111165_b0045","first-page":"3602","article-title":"Immunosuppression for 6\u20138 weeks after modified donor lymphocyte infusion reduced acute graft-versus-host disease without influencing graft-versus-leukemia effect in haploidentical transplant","volume":"127","author":"Yan","year":"2014","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.intimp.2023.111165_b0050","unstructured":"D. Przepiorka, D. Weisdorf, P. Martin, H.G. Klingemann, P. Beatty, J. Hows, et al., Consensus Conference on Acute GVHD Grading, Bone Marrow Transplant 1995 (15) (1994) 825\u2013828."},{"key":"10.1016\/j.intimp.2023.111165_b0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant J. Am. Soc. Blood Marrow Transplant"},{"key":"10.1016\/j.intimp.2023.111165_b0060","unstructured":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29872128\/ (accessed 27 Oct2023)."},{"key":"10.1016\/j.intimp.2023.111165_b0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.transproceed.2020.06.016","article-title":"Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation","volume":"53","author":"Aladag","year":"2021","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.intimp.2023.111165_b0070","doi-asserted-by":"crossref","unstructured":"S. Park, T.Y. Kim, J.H. Lee, J.Y. Lee, G.J. Min, S.S. Park et al., Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome, Ther. Adv. Hematol., 2021, 12, 20406207211043748.","DOI":"10.1177\/20406207211043748"},{"key":"10.1016\/j.intimp.2023.111165_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41409-021-01515-3","article-title":"Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia","volume":"57","author":"Schmid","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.111165_b0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00277-021-04731-5","article-title":"Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"101","author":"Harada","year":"2022","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.intimp.2023.111165_b0085","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood.V98.12.3456","article-title":"Durable engraftment of major histocompatibility complex\u2013incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide","volume":"98","author":"Luznik","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.111165_b0090","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.111165_b0095","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2015-01-623991","article-title":"Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide","volume":"125","author":"McCurdy","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.111165_b0100","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1200\/JCO.2013.54.0625","article-title":"Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning","volume":"32","author":"Kanakry","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.111165_b0105","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/bloodadvances.2021005847","article-title":"Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial","volume":"6","author":"Broers","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2023.111165_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12185-021-03228-1","article-title":"A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related\/unrelated allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Nakamae","year":"2022","journal-title":"Int. J. Hematol."},{"issue":"146","key":"10.1016\/j.intimp.2023.111165_b0115","first-page":"1402","article-title":"Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice","volume":"1991","author":"Eto","year":"1950","journal-title":"J. Immunol. Baltim. Md."},{"key":"10.1016\/j.intimp.2023.111165_b0120","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2023.111165_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.2021015129","article-title":"How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond","volume":"141","author":"Rimando","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.111165_b0130","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41409-019-0475-7","volume":"54","author":"Fayard","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.111165_b0135","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.111165_b0140","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"508","key":"10.1016\/j.intimp.2023.111165_b0145","first-page":"e1","article-title":"Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome","volume":"28","author":"Little","year":"2022","journal-title":"Transplant Cell Ther."},{"key":"10.1016\/j.intimp.2023.111165_b0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/JBM.S201073","article-title":"Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation","volume":"10","author":"Chang","year":"2019","journal-title":"J Blood Med."},{"key":"10.1016\/j.intimp.2023.111165_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101092","article-title":"Does PTCY increase the risk of infections?","author":"Mikulska","year":"2023","journal-title":"Blood Rev."},{"key":"10.1016\/j.intimp.2023.111165_b0160","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/bloodadvances.2022008792","article-title":"Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant","volume":"7","author":"P\u00e9rez-Valencia","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2023.111165_b0165","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tid.12455","article-title":"Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients","volume":"17","author":"Ruggeri","year":"2015","journal-title":"Transpl. Infect. Dis."},{"issue":"695","key":"10.1016\/j.intimp.2023.111165_b0170","first-page":"e1","article-title":"Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation","volume":"28","author":"Mehta","year":"2022","journal-title":"Transplant Cell Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:10:51Z","timestamp":1761588651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923014911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":34,"alternative-id":["S1567576923014911"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111165","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111165"}}